Clinical trial
An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in…
NCT00240799 · Johnson & Johnson Consumer and Personal Products Worldwide, Industry · Completed
Key facts
| NCT number | NCT00240799 |
|---|---|
| Title | An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee. |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Acetaminophen Extended Release (3900 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee. |
| Lead sponsor | Johnson & Johnson Consumer and Personal Products Worldwide, Industry |
| Collaborators | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | acetaminophen extended release, placebo |
| Enrollment | 542 |
| Completion | Oct 1, 2004 |
| First posted | Oct 18, 2005 |
| Last update posted | Jun 19, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: